PDF(Pubmed)
Abstract：
UNASSIGNED: The study aimed to demonstrate the efficacy and safety of an innovative hemostatic technique in managing Placenta Previa and Accreta Spectrum by S. Rao Spiral Suturing (SRSS) of a lower uterine segment.
UNASSIGNED: In this retrospective study conducted at Department of Obstetrics & Gynecology Unit-II of Nishtar Medical University, Multan between December 2018 to January 2021, one hundred and thirty consenting patients\' clinical records were reviewed with major degree placenta previa/placenta accrete spectrum, either operated electively or presented in an emergency, with or without a history of previous cesarean section. The enrolled patients underwent SRSS, procedure\'s efficacy and safety were measured by the number of obstetrical hysterectomies, the time required for the procedure, estimated blood loss, blood transfusion volume, need for any other hemostatic technique, bladder trauma, pelvic infection, scar site hematoma or abscess, sepsis, duration of hospital stay and maternal mortality.
UNASSIGNED: Out of 130 patients, 17(12.6%) had Placenta Accreta, 86(66.3%) Increta, and 27(21%) Percreta. The Placenta location was anterior dominant in 102(78.4%) cases and posterior in 17(8.4%). Of the patients who underwent surgery, only two required obstetrical hysterectomy due to uncontrolled bleeding. The procedure took three to five minutes in 127 patients and five to seven minutes in three patients. Regarding intraoperative blood transfusion, 54.6% of patients were transfused 1000-2000 ml blood, and 5.38% required > 3000 ml. No blood transfusion was required postoperatively in any patient. Postpartum hemorrhage, infection, fever, and sepsis were not observed in any patient postoperatively. None of the patients suffered bladder injury. All patients were discharged as per routine.
UNASSIGNED: SRSS is an innovative, safe, effective, and simple suturing technique for patients with Placenta Previa and Accreta spectrum.
UNASSIGNED: In this retrospective study conducted at Department of Obstetrics & Gynecology Unit-II of Nishtar Medical University, Multan between December 2018 to January 2021, one hundred and thirty consenting patients\' clinical records were reviewed with major degree placenta previa/placenta accrete spectrum, either operated electively or presented in an emergency, with or without a history of previous cesarean section. The enrolled patients underwent SRSS, procedure\'s efficacy and safety were measured by the number of obstetrical hysterectomies, the time required for the procedure, estimated blood loss, blood transfusion volume, need for any other hemostatic technique, bladder trauma, pelvic infection, scar site hematoma or abscess, sepsis, duration of hospital stay and maternal mortality.
UNASSIGNED: Out of 130 patients, 17(12.6%) had Placenta Accreta, 86(66.3%) Increta, and 27(21%) Percreta. The Placenta location was anterior dominant in 102(78.4%) cases and posterior in 17(8.4%). Of the patients who underwent surgery, only two required obstetrical hysterectomy due to uncontrolled bleeding. The procedure took three to five minutes in 127 patients and five to seven minutes in three patients. Regarding intraoperative blood transfusion, 54.6% of patients were transfused 1000-2000 ml blood, and 5.38% required > 3000 ml. No blood transfusion was required postoperatively in any patient. Postpartum hemorrhage, infection, fever, and sepsis were not observed in any patient postoperatively. None of the patients suffered bladder injury. All patients were discharged as per routine.
UNASSIGNED: SRSS is an innovative, safe, effective, and simple suturing technique for patients with Placenta Previa and Accreta spectrum.
摘要：
■该研究旨在证明一种创新的止血技术在子宫下段S.Rao螺旋缝合术（SRSS）治疗前置胎盘和植入频谱中的有效性和安全性。
■在Nishtar医科大学妇产科第二单元进行的这项回顾性研究中，Multan在2018年12月至2021年1月期间，对一百三十名同意的患者的临床记录进行了评估，并采用了主要程度的前置胎盘/胎盘植入谱，选择操作或在紧急情况下出现，有或没有剖宫产史。入选患者接受了SRSS，手术的有效性和安全性通过产科子宫切除术的数量来衡量，手术所需的时间，估计失血量,输血量,需要任何其他止血技术，膀胱外伤,盆腔感染,瘢痕部位血肿或脓肿，脓毒症,住院时间和孕产妇死亡率。
■在130名患者中，17人（12.6%）有胎盘植入，86（66.3%），和27（21％）Percreta。胎盘位置在102例（78.4％）中占前部，在17例（8.4％）中占后部。在接受手术的病人中，由于未控制的出血，只有2例需要产科子宫切除术。127名患者的手术时间为3至5分钟，3名患者的手术时间为5至7分钟。关于术中输血，54.6%的患者输血1000-2000毫升,和5.38%需要>3000毫升。任何患者术后均不需要输血。产后出血,感染,发烧,术后未在任何患者中观察到脓毒症。没有患者遭受膀胱损伤。所有患者均按常规出院。
■SRSS是一种创新，安全,有效,前置胎盘和Accreta频谱患者的简单缝合技术。
■在Nishtar医科大学妇产科第二单元进行的这项回顾性研究中，Multan在2018年12月至2021年1月期间，对一百三十名同意的患者的临床记录进行了评估，并采用了主要程度的前置胎盘/胎盘植入谱，选择操作或在紧急情况下出现，有或没有剖宫产史。入选患者接受了SRSS，手术的有效性和安全性通过产科子宫切除术的数量来衡量，手术所需的时间，估计失血量,输血量,需要任何其他止血技术，膀胱外伤,盆腔感染,瘢痕部位血肿或脓肿，脓毒症,住院时间和孕产妇死亡率。
■在130名患者中，17人（12.6%）有胎盘植入，86（66.3%），和27（21％）Percreta。胎盘位置在102例（78.4％）中占前部，在17例（8.4％）中占后部。在接受手术的病人中，由于未控制的出血，只有2例需要产科子宫切除术。127名患者的手术时间为3至5分钟，3名患者的手术时间为5至7分钟。关于术中输血，54.6%的患者输血1000-2000毫升,和5.38%需要>3000毫升。任何患者术后均不需要输血。产后出血,感染,发烧,术后未在任何患者中观察到脓毒症。没有患者遭受膀胱损伤。所有患者均按常规出院。
■SRSS是一种创新，安全,有效,前置胎盘和Accreta频谱患者的简单缝合技术。
